Blue Trust Inc’s Roivant Sciences ROIV Stock Holding History

Blue Trust Inc’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.33K	Sell	179 -14	-7%	-$414	﹤0.01%	1982
2026 Q1	$5.35K	Sell	193 -223	-54%	-$5.73K	﹤0.01%	1976
2025 Q4	$9.03K	Buy	+416	New	+$8.21K	﹤0.01%	1888
2025 Q3	–	Sell	-725	Closed	-$8.17K	–	2664
2025 Q2	$8.17K	Sell	725 -119	-14%	-$1.29K	﹤0.01%	1920
2025 Q1	$8.52K	Hold	844	–	–	﹤0.01%	1964
2024 Q4	$9.98K	Sell	844 -368	-30%	-$4.35K	﹤0.01%	1865
2024 Q3	$12.8K	Buy	1,212 +123	+11%	+$1.4K	﹤0.01%	2106
2024 Q2	$11.5K	Buy	+1,089	New	+$11.9K	﹤0.01%	1884

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Blue Trust Inc's ROIV Position: Q2 2026 in Review

Blue Trust Inc reduced its Roivant Sciences (ROIV) stake by 7.3% in Q2 2026, selling an estimated $414 and leaving 179 shares worth $6.33K. The position accounts for ﹤0.01% of the portfolio, ranked #1982.

Blue Trust Inc first reported a position in ROIV in Q2 2024 and has held it in 8 quarters since. The position peaked at $12.8K in Q3 2024. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

Blue Trust Inc held 179 shares of Roivant Sciences worth $6.33K as of Q2 2026.
Blue Trust Inc sold 14 Roivant Sciences shares in Q2 2026, an estimated $414.
Roivant Sciences made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #1982 holding.
Blue Trust Inc first reported a position in Roivant Sciences in Q2 2024 and has held it in 8 quarters since.
Blue Trust Inc's Roivant Sciences position peaked at $12.8K in Q3 2024.
498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.